241 related articles for article (PubMed ID: 15024182)
1. Circulating CD4+CD25+ T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs.
Putheti P; Pettersson A; Soderstrom M; Link H; Huang YM
J Clin Immunol; 2004 Mar; 24(2):155-61. PubMed ID: 15024182
[TBL] [Abstract][Full Text] [Related]
2. Effect of glatiramer acetate (Copaxone) on CD4+CD25high T regulatory cells and their IL-10 production in multiple sclerosis.
Putheti P; Soderstrom M; Link H; Huang YM
J Neuroimmunol; 2003 Nov; 144(1-2):125-31. PubMed ID: 14597106
[TBL] [Abstract][Full Text] [Related]
3. Multiple sclerosis: expression of CD1a and production of IL-12p70 and IFN-gamma by blood mononuclear cells in patients on combination therapy with IFN-beta and glatiramer acetate compared to monotherapy with IFN-beta.
Hussien Y; Sanna A; Söderström M; Link H; Huang YM
Mult Scler; 2004 Feb; 10(1):16-25. PubMed ID: 14760948
[TBL] [Abstract][Full Text] [Related]
4. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
[TBL] [Abstract][Full Text] [Related]
5. Time-course analysis of CD25 and HLA-DR expression on lymphocytes in interferon-beta 1b-treated multiple sclerosis patients.
Ferrarini AM; Sivieri S; Buttarello M; Facchinetti A; Perini P; Gallo P
Mult Scler; 1998 Jun; 4(3):174-7. PubMed ID: 9762669
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of TRAIL expression on human T lymphocytes by interferon beta and glatiramer acetate.
Arbour N; Rastikerdar E; McCrea E; Lapierre Y; Dörr J; Bar-Or A; Antel JP
Mult Scler; 2005 Dec; 11(6):652-7. PubMed ID: 16320724
[TBL] [Abstract][Full Text] [Related]
7. Increased population of CD4(+)CD25(high), regulatory T cells with their higher apoptotic and proliferating status in peripheral blood of acute myeloid leukemia patients.
Wang X; Zheng J; Liu J; Yao J; He Y; Li X; Yu J; Yang J; Liu Z; Huang S
Eur J Haematol; 2005 Dec; 75(6):468-76. PubMed ID: 16313258
[TBL] [Abstract][Full Text] [Related]
8. Monocyte-derived HLA-G acts as a strong inhibitor of autologous CD4 T cell activation and is upregulated by interferon-beta in vitro and in vivo: rationale for the therapy of multiple sclerosis.
Mitsdoerffer M; Schreiner B; Kieseier BC; Neuhaus O; Dichgans J; Hartung HP; Weller M; Wiendl H
J Neuroimmunol; 2005 Feb; 159(1-2):155-64. PubMed ID: 15652415
[TBL] [Abstract][Full Text] [Related]
9. Acquisition of anergic and suppressive activities in transforming growth factor-beta-costimulated CD4+CD25- T cells.
Park HB; Paik DJ; Jang E; Hong S; Youn J
Int Immunol; 2004 Aug; 16(8):1203-13. PubMed ID: 15237111
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic modulation of CD4+CD25(high) regulatory T lymphocytes in multiple sclerosis patients during interferon-β therapy.
Cosentino M; Zaffaroni M; Trojano M; Giorelli M; Pica C; Rasini E; Bombelli R; Ferrari M; Ghezzi A; Comi G; Livrea P; Lecchini S; Marino F
Neuroimmunomodulation; 2012; 19(5):283-92. PubMed ID: 22472872
[TBL] [Abstract][Full Text] [Related]
11. Abnormalities of CD4 T cell subpopulations in ANCA-associated vasculitis.
Marinaki S; Neumann I; Kälsch AI; Grimminger P; Breedijk A; Birck R; Schmitt W; Waldherr R; Yard BA; Van Der Woude FJ
Clin Exp Immunol; 2005 Apr; 140(1):181-91. PubMed ID: 15762890
[TBL] [Abstract][Full Text] [Related]
12. Effect of IFN-beta therapy on the frequency and function of CD4(+)CD25(+) regulatory T cells and Foxp3 gene expression in relapsing-remitting multiple sclerosis (RRMS): a preliminary study.
Namdar A; Nikbin B; Ghabaee M; Bayati A; Izad M
J Neuroimmunol; 2010 Jan; 218(1-2):120-4. PubMed ID: 19932513
[TBL] [Abstract][Full Text] [Related]
13. Pharmacogenomics of interferon beta and glatiramer acetate response: a review of the literature.
Mahurkar S; Suppiah V; O'Doherty C
Autoimmun Rev; 2014 Feb; 13(2):178-86. PubMed ID: 24189284
[TBL] [Abstract][Full Text] [Related]
14. Glatiramer acetate and IFN-beta act on dendritic cells in multiple sclerosis.
Hussien Y; Sanna A; Söderström M; Link H; Huang YM
J Neuroimmunol; 2001 Dec; 121(1-2):102-10. PubMed ID: 11730946
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cell, monocyte and T cell activation and response to glatiramer acetate in multiple sclerosis.
Sellebjerg F; Hesse D; Limborg S; Lund H; Søndergaard HB; Krakauer M; Sørensen PS
Mult Scler; 2013 Feb; 19(2):179-87. PubMed ID: 22653658
[TBL] [Abstract][Full Text] [Related]
16. Circulating CD4+CD25+ and CD4+CD25+ T cells in myasthenia gravis and in relation to thymectomy.
Huang YM; Pirskanen R; Giscombe R; Link H; Lefvert AK
Scand J Immunol; 2004 Apr; 59(4):408-14. PubMed ID: 15049785
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic induction of regulatory, cytotoxic CD8+ T cells in multiple sclerosis.
Tennakoon DK; Mehta RS; Ortega SB; Bhoj V; Racke MK; Karandikar NJ
J Immunol; 2006 Jun; 176(11):7119-29. PubMed ID: 16709875
[TBL] [Abstract][Full Text] [Related]
18. Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis.
Karandikar NJ; Crawford MP; Yan X; Ratts RB; Brenchley JM; Ambrozak DR; Lovett-Racke AE; Frohman EM; Stastny P; Douek DC; Koup RA; Racke MK
J Clin Invest; 2002 Mar; 109(5):641-9. PubMed ID: 11877472
[TBL] [Abstract][Full Text] [Related]
19. Multiple sclerosis: a study of chemokine receptors and regulatory T cells in relation to MRI variables.
Putheti P; Morris M; Stawiarz L; Teleshova N; Kivisäkk P; Pashenkov M; Kouwenhoven M; Wiberg MK; Bronge L; Huang YM; Söderström M; Hillert J; Link H
Eur J Neurol; 2003 Sep; 10(5):529-35. PubMed ID: 12940835
[TBL] [Abstract][Full Text] [Related]
20. Effect of immunomodulatory treatment of multiple sclerosis on lymphocyte surface immunomarkers.
Michałowska-Wender G; Losy J; Wender M; Januszkiewicz-Lewandowska D; Nowak J
Pol J Pharmacol; 2003; 55(5):877-80. PubMed ID: 14704481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
